Skip to main content
. 2017 Dec 13;2017(12):CD000467. doi: 10.1002/14651858.CD000467.pub2

Comparison 1. CCBs vs placebo (generic inverse variance method).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Frequency of attacks (average/week) 23 1024 Mean Difference (Fixed, 95% CI) ‐6.07 [‐6.53, ‐5.61]
2 Frequency of attacks (average/week) 22   Mean Difference (Fixed, 95% CI) ‐2.93 [‐3.44, ‐2.43]
3 Duration of attacks (minutes) 6 138 Mean Difference (Fixed, 95% CI) ‐1.67 [‐3.29, ‐0.04]
4 Severity of attacks (average, on a 10‐cm VAS) 16 748 Risk Difference (Fixed, 95% CI) ‐0.62 [‐0.72, ‐0.51]
5 Pain (10‐cm visual analogue scale) 4 124 Std. Mean Difference (Fixed, 95% CI) ‐1.47 [‐2.21, ‐0.74]
6 Patient global 2 192 Std. Mean Difference (Fixed, 95% CI) ‐0.37 [‐0.73, ‐0.02]
7 Number of withdrawals (due to treatment) 2 63 Risk Ratio (M‐H, Fixed, 95% CI) 1.30 [0.51, 3.33]